Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis (Q45258208)

8

object named as

Ellie J C Goldstein

1 reference

11 December 2017

7

Kerin L Tyrrell

1 reference

11 December 2017

6

Diane M Citron

1 reference

11 December 2017

Gary E Stein

1

1 reference

11 December 2017

Sharon L Schooley

2

1 reference

11 December 2017

Charles A Peloquin

3

1 reference

11 December 2017

Vivek Kak

4

1 reference

11 December 2017

Daniel H Havlichek

Annals of Pharmacotherapy

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

8 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

39

1 reference

11 December 2017

427-432

1 reference

11 December 2017

3

1 reference

11 December 2017

Control of multiply resistant cocci: do international comparisons help?

1 reference

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

21 January 2018

1 reference

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen

21 January 2018

1 reference

Quinupristin-dalfopristin and linezolid: evidence and opinion

21 January 2018

1 reference

The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species

21 January 2018

1 reference

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

21 January 2018

1 reference

Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci

21 January 2018

1 reference

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

21 January 2018

1 reference

Antimicrobial dosing in obese patients

21 January 2018

1 reference

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review

21 January 2018

1 reference

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

21 January 2018

1 reference

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers

21 January 2018

1 reference

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program

21 January 2018

1 reference

Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model

21 January 2018

1 reference

Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

An in vitro time-kill assessment of linezolid and anaerobic bacteria

21 January 2018

1 reference

Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli

21 January 2018

1 reference

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

21 January 2018

1 reference

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

21 January 2018

1 reference

Linezolid pharmacokinetics in adult patients with cystic fibrosis

21 January 2018

1 reference

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

21 January 2018

1 reference

Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid

21 January 2018

1 reference

Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Linezolid in the treatment of osteomyelitis: results of compassionate use experience

21 January 2018

1 reference

release_gluizd7hyfdo5c7dassgn3byni

21 January 2018

Identifiers

1 reference

11 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gluizd7hyfdo5c7dassgn3byni